Patients receiving immunotherapy report it is effective as assessed by therhinitis outcomes questionnaire (ROQ) in a private practice setting

Citation
J. Santilli et al., Patients receiving immunotherapy report it is effective as assessed by therhinitis outcomes questionnaire (ROQ) in a private practice setting, ANN ALLER A, 86(2), 2001, pp. 219-221
Citations number
4
Categorie Soggetti
Clinical Immunolgy & Infectious Disease
Journal title
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
ISSN journal
10811206 → ACNP
Volume
86
Issue
2
Year of publication
2001
Pages
219 - 221
Database
ISI
SICI code
1081-1206(200102)86:2<219:PRIRII>2.0.ZU;2-4
Abstract
Background: Outcomes measurement is a proficient method in determining the effectiveness of medical therapy. Currently, there are no easy-to-use and i nexpensive questionnaires available to evaluate the effectiveness of immuno therapy by allergists in private practice. Objective: To evaluate the effectiveness of immunotherapy in the treatment of patients with allergic rhinitis in a private practice setting using the rhinitis outcomes questionnaire (ROQ). Methods: One hundred seventy-five patients were randomly chosen from three private practices nationwide. They were surveyed regarding global systemic problems and nasal, eye, and chest symptoms, as well as their medical treat ment history. This questionnaire was administered twice in one sitting, wit h the first a recall of symptoms before immunotherapy treatment, and the se cond an evaluation of current symptoms. Results: The data revealed that 81% of the patients believed immunotherapy worked, with 19% unsure. Patients experienced a 67% decrease in antibiotic use, a 68% decrease in emergency room visits, a 75% decrease in days lost f rom work or school, and a 79% decrease in hospital admissions. The average symptom score reduction with immunotherapy was 52%. Conclusions: This study demonstrates that the user-friendly ROQ can be effe ctively and inexpensively used in a private practice setting and that immun otherapy is effective in the treatment of allergic rhinitis.